Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections

Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections

As bioactive small proteins with antimicrobial and immunomodulatory activities that are naturally produced by all living organisms, antimicrobial peptides (AMPs) have a marked potential as next-generation antibiotics. However, their development as antibacterial agents is limited by low stability and...

Full description

Bibliographic Details
Main Authors:	Margherita Degasperi, Riccardo Sgarra, Mario Mardirossian, Sabrina Pacor, Massimo Maschio, Marco Scocchi
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Antibiotics
Subjects:	antimicrobial peptide cystic fibrosis pro-drug elastase <i>Pseudomonas aeruginosa</i>
Online Access:	https://www.mdpi.com/2079-6382/11/3/319

Similar Items

The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity
by: Margherita Degasperi, et al.
Published: (2020-09-01)

Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage
by: Nina Erdmann, et al.
Published: (2022-11-01)

D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection
by: Mario Mardirossian, et al.
Published: (2017-06-01)

Detection of Morphotyping Characteristics Identification Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis
by: Hossein Fazeli, et al.
Published: (2012-03-01)

THE PREVALENCE OF PSEUDOMONAS AERUGINOSA STRAINS IN INFANTS WITH CYSTIC FIBROSIS WITHIN A HOSPITAL IN NORTH EASTER OF ROMANIA
by: Oana Alexandra Ciocan, et al.
Published: (2016-11-01)

Overexpression and Characterization of Organic Solvent-Tolerant Elastase Strain K In Newly Constructed Vectors
by: Wong, Chee Fah
Published: (2010)

The Impact of <i>Pseudomonas aeruginosa</i> Infection in Adult Cystic Fibrosis Patients—A Single Polish Centre Study
by: Sylwia Jarzynka, et al.
Published: (2023-12-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran
by: Hossein Fazeli, et al.
Published: (2013-01-01)

Antibiotherapy in Children with Cystic Fibrosis—An Extensive Review
by: Ioana Mihaiela Ciuca, et al.
Published: (2022-08-01)

Evaluation of a Novel Chromogenic Medium for the Detection of <i>Pseudomonas aeruginosa</i> in Respiratory Samples from Patients with Cystic Fibrosis
by: Thang V. Truong, et al.
Published: (2022-05-01)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023-06-01)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021-07-01)

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis
by: Abdullah A. Tarique, et al.
Published: (2024-01-01)

A Metagenomic approach to characterize temperate bacteriophage populations from cystic fibrosis and non-cystic fibrosis bronchiectasis patients
by: Mohammad Adnan Tariq, et al.
Published: (2015-02-01)

Factoring in the Complexity of the Cystic Fibrosis Lung to Understand <i>Aspergillus fumigatus</i> and <i>Pseudomonas</i> <i>aeruginosa</i> Interactions
by: Emily Beswick, et al.
Published: (2020-08-01)

<i>Pseudomonas aeruginosa</i> PAO1 Is Attracted to Bovine Bile in a Novel, Cystic Fibrosis-Derived Bronchial Epithelial Cell Model
by: Shekooh Behroozian, et al.
Published: (2022-03-01)

Interspecies Metabolic Complementation in Cystic Fibrosis Pathogens via Purine Exchange
by: Hafij Al Mahmud, et al.
Published: (2021-02-01)

Anti-Virulence Properties of <i>Coridothymus capitatus</i> Essential Oil against <i>Pseudomonas aeruginosa</i> Clinical Isolates from Cystic Fibrosis Patients
by: Gianluca Vrenna, et al.
Published: (2021-10-01)

<i>Lactobacillus</i> Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of <i>Pseudomonas aeruginosa</i> from Cystic Fibrosis Lung
by: Giovanna Batoni, et al.
Published: (2023-06-01)

<i>Scedosporium/Lomentospora</i> Species Induce the Production of Siderophores by <i>Pseudomonas aeruginosa</i> in a Cystic Fibrosis Mimic Environment
by: Thaís P. Mello, et al.
Published: (2023-04-01)

Microbiological features of Pseudomonas aeruginosa in children with Cystic Fibrosis
by: O.V. Ishchenko, et al.
Published: (2021-09-01)

γδ T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-α and IFN-γ-producers in response to <it>Pseudomonas aeruginosa</it>
by: Martínez Natalia, et al.
Published: (2003-09-01)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
by: Argyri Petrocheilou, et al.
Published: (2022-12-01)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
by: Nicole Acosta, et al.
Published: (2020-04-01)

Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center
by: Danish Abdul Aziz, et al.
Published: (2022-01-01)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Jingming Zhao, et al.
Published: (2018-11-01)

Essential Oils Biofilm Modulation Activity and Machine Learning Analysis on <i>Pseudomonas aeruginosa</i> Isolates from Cystic Fibrosis Patients
by: Marco Artini, et al.
Published: (2022-04-01)

Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of <i>Pseudomonas aeruginosa</i> under Conditions Relevant to Cystic Fibrosis
by: Giovanna Batoni, et al.
Published: (2023-07-01)

Effects of Levofloxacin, Aztreonam, and Colistin on Enzyme Synthesis by <i>P. aeruginosa</i> Isolated from Cystic Fibrosis Patients
by: Arianna Pani, et al.
Published: (2022-08-01)

Anti-Virulence Activity of the Cell-Free Supernatant of the Antarctic Bacterium <i>Psychrobacter</i> sp. TAE2020 against <i>Pseudomonas aeruginosa</i> Clinical Isolates from Cystic Fibrosis Patients
by: Rosanna Papa, et al.
Published: (2021-08-01)

Fibroblast Growth Factor 23 Signaling Does Not Increase Inflammation from <i>Pseudomonas aeruginosa</i> Infection in the Cystic Fibrosis Bronchial Epithelium
by: Meghan June Hirsch, et al.
Published: (2023-09-01)

Development of Quinazolinone Derivatives as Modulators of Virulence Factors of <i>Pseudomonas aeruginosa</i> Cystic Fibrosis Strains
by: Gabriele Carullo, et al.
Published: (2023-09-01)

Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells
by: Sylvain Brax, et al.
Published: (2024-06-01)

Novel Antioxidant Therapy with the Immediate Precursor to Glutathione, γ-Glutamylcysteine (GGC), Ameliorates LPS-Induced Cellular Stress in In Vitro 3D-Differentiated Airway Model from Primary Cystic Fibrosis Human Bronchial Cells
by: Chris K. Hewson, et al.
Published: (2020-11-01)

Insights on <i>Pseudomonas aeruginosa</i> Carbohydrate Binding from Profiles of Cystic Fibrosis Isolates Using Multivalent Fluorescent Glycopolymers Bearing Pendant Monosaccharides
by: Deborah L. Chance, et al.
Published: (2024-04-01)

Organisms isolated from adults with Cystic Fibrosis
by: Moore John E, et al.
Published: (2004-12-01)

Abnormal functional lymphoid tolerance and enhanced myeloid exocytosis are characteristics of resting and stimulated PBMCs in cystic fibrosis patients
by: Clémence Gaudin, et al.
Published: (2024-02-01)

Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis
by: Catherine R. Armbruster, et al.
Published: (2022-10-01)

A Novel Co-Culture Model Reveals Enhanced CFTR Rescue in Primary Cystic Fibrosis Airway Epithelial Cultures with Persistent <i>Pseudomonas aeruginosa</i> Infection
by: Deborah M. Cholon, et al.
Published: (2023-11-01)